British Ambassador hosts Gala Dinner for BioEDEN Mexico in Official Residence

On September 8, BioEDEN Mexico held a gala dinner at the official residence of Judith Macgregor, Her Majesty’s British Ambassador. Guests included leading members of the health sector and prestigious dentists in Mexico, business leaders, politicians and researchers

Read Article

UK Prime Minister meets with BioEDEN

During his recent visit to the newly announced Enterprise Zone at the Daresbury Science and Innovation Campus, the Prime Minister took time out to meet with BioEDEN.

Read Article

Medical News Today (USA)

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: 1. Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and 2. Adult tissue (adult stem cells). Both types are generally characterized by their potency, or potential to differentiate into different cell types (such as skin, muscle, bone, etc).

Read Article

NHS (UK)

The Department of Health has warned that “rogue clinics” are offering risky stem cell treatment. This follows a warning by the Multiple Sclerosis society that despite there being no scientific evidence for using stem cells to treat MS, a company in the Seychelles is approaching MS patients to sell them treatment. In addition, newspapers have reported that the International Society for Stem Cell Research (ISSCR) has stated that stem cell clinics around the world are exploiting patients by offering, “supposed stem cell therapies without credible scientific rationale, oversight or other patient protections”.

Read Article

Diabetes.co.uk (UK)

A new study has found that dental stem cells could offer a possible treatment for type 1 diabetes, it has emerged. It is hoped that the research, which revealed that transforming stem cells from teeth into cells that produce insulin, could provide a potential cure for the disease.

Read Article

University of Michigan

The University of Michigan is a long-time leader in the study of adult stem cells. But until Michigan voters approved a state constitutional amendment in November 2008, restrictive state laws severely limited the types of embryonic stem cell research allowed in the state. In response to the passage of Proposal 2 in November 2008, U-M is bolstering its embryonic stem cell research effort. New research initiatives and collaborations are in the works, new faculty members are being hired, and the university is now positioned to compete for any new federal funds that become available for embryonic stem cell research.

Read Article

National Institutes of Health (USA)

This primer on stem cells is intended for anyone who wishes to learn more about the biological properties of stem cells, the important questions about stem cells that are the focus of scientific research, and the potential use of stem cells in research and in treating disease. The primer includes information about stem cells derived from embryonic and non-embryonic tissues.

Read Article

First Dental & Craniofacial Stem Cell Conference

The First International Conference on Dental and Craniofacial Stem Cells will take place April 27-29, 2011, at the New York Academy of Sciences in New York City. The conference will be an assembly many of the world's most prominent scientists in the field of dental and craniofacial stem cells, as well as the emerging field of regenerative dental medicine.

Read Article